Skip to main content
Caplight Logo









Hillo

Hillo

Private
Boulogne-BillancourtHealthcare & Life Scienceshttps://www.hillo.ai/

Last Round

M&A

Mar 1, 2025

Total Funding Raised

$940,000

Company Overview

Hillo operates in Healthcare & Life Sciences and is based in Boulogne-Billancourt. Its latest recorded funding round was a Seed round in September 2018.

Hillo is a healthtech company that provides an AI-based clinical decision support platform for diabetes management.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Precision Medicine, Medical Devices, API Management

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Hillo Comparables

Compare Hillo with similar companies based on industry and business-model similarity.

Hillo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Health2Sync
79%
Glooko
75%
Twin Health
64%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Hillo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AMar 1, 2025
SeedSep 25, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Hillo Investors

Notable investors and investment history

Book a demo to see all 8 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2025

    Grew 51% QoQ, from 39 to 59 employees.

  • Sep 25, 2018

    $940K raised from NCI, GO Capital, and Angels Santé.

Book a demo to see all signals

For institutional investors. Book with your work email.

Hillo Filings

Explore SEC and related filing metadata, where available.

Hillo filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Hillo's valuation, stock price, and market status.

Is Hillo a public or private company?

Hillo is a private company.

What is the current stock price of Hillo?

Hillo is a private company, so its shares have no public market price. Caplight tracks Hillo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Hillo worth (valuation)?

Valuation information for Hillo is not publicly available.

Can I buy Hillo stock?

Hillo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Hillo's last funding round?

Hillo's most recent funding round was M&A on March 1, 2025.

Who are the main investors in Hillo?

Key investors in Hillo include European Innovation Council Fund, Paris Business Angels, Arts et Métiers Business Angels, GO Capital, Angels Santé.

Will Hillo IPO soon?

No public IPO plans have been announced for Hillo.

How can I track Hillo secondary market activity?

Caplight tracks bids, offers, and trades in Hillo's shares on secondary markets.

Firmographic Details

HeadquartersBoulogne-Billancourt
Employee Range51
Year Founded2019
Last FundingMar 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?